Stocks Hitting 52-Week Highs

By: via Benzinga
Halozyme Therapeutics, Inc. (NASDAQ: HALO) shares reached a new 52-week high of $20.335. Halozyme Therapeutics announced the ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.